Gilead Sciences reported survey findings on PrEP access and utilization in the US during COVID-19 shelter-in-place orders
On Jul. 8, 2020, Gilead Sciences announced data evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP…
Long-acting injectable form of HIV prevention outperformed daily pill in NIH study
On Jul. 7, 2020, a pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug…
Merck announced analyses showing additional safety and efficacy data for investigational Islatravir in combination with Doravirine in adults with HIV-1 infection
On Jul. 6, 2020, Merck announced a new analyses from the Phase 2b trial evaluating the safety and…
Biotechnology | FDA | HIV | Life Science News | Therapeutics
The FDA approved new HIV treatment for patients with limited treatment options
On Jul. 2, 2020, the U.S. Food and Drug Administration (FDA) approved Rukobia (fostemsavir), a new type of…
ViiV Healthcare announced FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults
On Jul. 2, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
Biotechnology | CDC | HIV | Life Science News | Therapeutics
The FDA approved drug to treat infants and children with HIV
On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…
ViiV Healthcare announced FDA approval of the first-ever dispersible tablet formulation of dolutegravir for children living with HIV
On Jun. 12, 2020, ViiV Healthcare, a GSK company, with Pfizer and Shionogi Limited, announced the FDA had…
Brain cells can harbor and spread HIV virus to the body
On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…
Biotechnology | HIV | Life Science News | NIH
Just – Evotec Biologics partnered with ABL on development of broadly neutralising antibody against HIV
On Jun. 8, 2020, Evotec announced that its Seattle-based subsidiary Just – Evotec Biologics had entered into an…
Study confirmed effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
Long-acting injectable drug prevents HIV among men and transgender women
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
Electron microscopy technique revealed how a key human antibody disarms many strains of HIV
On Apr. 29, 2020, Scripps researchers announced they had developed a method for examining the machinery of HIV…
Potential new HIV treatment developed at University of Nebraska Medical Center
On Apr. 27, 2020, a novel means to prevent HIV infection was developed at the University of Nebraska…
First patients enrolled in new Oxford University clinical trial of possible COVID-19 treatments
On Mar. 23, 2020, researchers from the University of Oxford the launch of a new clinical trial to…
Newer anti-HIV drugs safest, most effective during pregnancy
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
ImmunityBio announced durable virus control of SHIV without anti-retroviral therapy
On Mar. 10, 2020, ImmunityBio announced results from studies evaluating N-803, an IL-15 superagonist, alone and in combination…
Biotechnology | HIV | Life Science News | NIH
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
NIHs Study found lower concentration of PrEP drug in young women during pregnancy than postpartum
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
Biotechnology | Diagnostics | Genomics | HIV | Infectious Disease | Life Science News | Therapeutics
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
Chembio Diagnostics received WHO prequalification approval for HIV Self-Test
On Nov. 4, 2019, Chembio Diagnostics announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO)…
Biotechnology | CDC | Disease | HIV | Life Science News | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of meningococcal conjugate vaccines in HIV-infected persons
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
HIV research cleared name of ‘Patient Zero,’ Gaetan Dugas
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
UNMC researchers probed aging, HIV-infected brain with $22 million NIH grant
On Apr. 4, 2016, UNMC researchers, Tony Wilson, Ph.D., and Susan Swindells, M.B.B.S., working with a $2.2 million,…
The New England Primate Research Center closed its doors
On May 31, 2015, the New England Primate Research Center (NEPRC) closed its doors. During its five decades…
OHSU scientist awarded $25 million grant to further HIV vaccine research
On Sept. 3, 2014, Oregon Health & Science University (OHSU) announced it had been awarded a $25 million…
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
HIV/AIDS researcher David Ho won NIDA’s 2011 Avant-Garde Award
On Aug. 12, 2011, the National Institute on Drug Abuse (NIDA), part of NIH, announced that Dr. David…